Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies
![Newspaper Chart icon on shiny red circle button.](/en/-/media/PHD-Images/Icons/GL-Hub-Icons/phd_gl_hub_science_news.png?h=65&iar=0&mw=1910&w=65&sc_lang=en)
Science News
Science News Summary
Related Journal Article
Preamble: Principles, and General Considerations
Task Force 1: Classification of Sports: Dynamic, Static and Impact
Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes
Task Force 4: Congenital Heart Disease
Task Force 7: Aortic Diseases, Including Marfan Syndrome
Task Force 8: Coronary Artery Disease
Task Force 9: Arrhythmias and Conduction Defects
Task Force 10: The Cardiac Channelopathies
Task Force 11: Drugs and Performance Enhancing Substances
Task Force 12: Emergency Action Plans, Resuscitation, CPR, and AEDs
Task Force 13: Commotio Cordis
Task Force 14: Sickle Cell Trait
Task Force 15: Legal Aspects of Medical Eligibility and Disqualification Recommendations
![phd_gl_hub_recommended_reading](/en/-/media/PHD-Images/Icons/GL-Hub-Icons/phd_gl_hub_recommended_reading.png?h=65&iar=0&mw=1910&w=65&sc_lang=en)